India’s weight-loss price war begins as semaglutide patent expires
--------------------------------------------------------------------
Source: South China Morning Post
Published: 2026-03-19 23:19 UTC+10:00
Section: Namita Joshi
Factuality Score: 90
Opinion Category: Neutral
Topics: Culture & Entertainment, Indigenous, Military & Defence, Lifestyle, Natural Disasters, Economy & Finance, Financial Markets, India, Drugs, Business & Economy, Environment & Climate, War & Conflict, Asia Pacific
--------------------------------------------------------------------
Snippet:
Generic slimming drugs are expected to flood a market where one in four adults are currently either overweight or obese
--------------------------------------------------------------------